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Accepted 28 January 2013AbstractObjectives: The aim of this study was to analyze short-term outcomes of pelvic prolapse surgery using Prolift transvaginal mesh in a teaching
hospital.
Materials and Methods: Thirty-four patients who received prolapse surgery with Prolift were followed up for 7e26 months. Assessment
included pre- and postoperative Pelvic Organ Prolapse Quantification (POP-Q) stage, and Urogenital Distress Inventory (UDI)-6, and Incon-
tinence Impact Questionnaire (IIQ)-7 scores. Surgical characteristics and adverse events during follow-up were also recorded.
Results: Objective and subjective data were available for 29 patients. The overall anatomical success rate was 96.5 % (28/29) after a mean of
18  6.3 months follow-up. The POP-Q, UDI, and IIQ all improved significantly after surgery. Uterine sparing prolapsed surgery with Prolift
unexpectedly yielded a cure rate of 100%. Ten adverse events occurred during and after prolapse surgery with dyspareunia (3/34) as the most
common, followed by bladder injury (2/34).
Conclusions: Prolapse surgery with Prolift yielded a good anatomical outcome and satisfactory symptom improvement at different periods of
follow-up, especially in uterus-sparing prolapse surgery. However, adverse events were not uncommon, and patients should be fully informed of
all possible adverse events prior to surgery.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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Rising life expectancy and declining birth rates make for
rapid growth of an aging population in many countries. Age-
related health problems, including pelvic organ prolapse
(POP), have also become more prevalent in elderly women [1],
with a significant impact on their daily life, sexual function,
and exercise capacity.
Surgical treatment is indicated for symptomatic POP, such
as obstructed urination/defecation and sexual dysfunction, or
if there is failure of conservative treatment. The lifetime risk* Corresponding author. Department of Obstetrics and Gynecology,
Buddhist Tzu Chi General Hospital, Tzu Chi University, 707, Section 3,
Chung Yang Road, Hualien City, Hualien 970, Taiwan.
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http://dx.doi.org/10.1016/j.tjog.2013.01.026for women undergoing surgery for prolapse or incontinence
has been reported to be 11e19% [2,3]. Traditional prolapse
surgery, such as colporrhaphy with or without hysterectomy, is
associated with a recurrence or reoperation rate of 29.2e58%
[4,5]. These treatment failures may be due to the use of weak
native tissue.
The use of tension-free polypropylene mesh kits for repair
of POP has recently become more popular [6e9]. Prolift is a
wide, nonabsorbable mesh with an anchor system applied with
a minimally invasive technique to provide complete support by
reinforcing the pubocervical and rectovaginal fascia. It offers a
new mesh option for treating genital prolapse and can be
performed with or without vaginal hysterectomy [10,11].
However, recent studies on these devices are inconclusive as to
whether or not they result in better clinical outcomes than
traditional colporrhaphy [12]. The present study investigatedcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
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hospital in eastern Taiwan and analyzed the results in terms of
outcome.
Materials and methods
This retrospective study initially enrolled 42 patients who
underwent prolapse surgery by three surgeons (D.-C. Ding,
Y.-C. Wei, and T.-Y. Chu) using Prolift mesh at Buddhist Tzu
Chi General Hospital, Hualien, Taiwan during the period of
December 2008 to October 2010. Only 34 cases of prolapsed
surgery with either Total or Anterior/ Posterior Prolift pelvic
floor repair system (Ethicon, Somerville, NJ, USA) were
included; eight cases that used other devices were excluded
(Fig. 1). The hospital Research Ethics Committee approved
the study (IRB100-04).
The preoperative pelvic floor conditions were obtained by a
review of medical records. Patients were asked to return to the
patient department for further evaluation. The severity of POPFig. 1. Study design flow chart. IIQ-7 ¼ Incontinence Impact Questionnaire-7;
POP-Q ¼ Pelvic Organ Prolapse Quantification; UDI-6 ¼ Urogenital Distress
Inventory-6.was measured in the lithotomy position pre- and post-
operatively with full Valsalva maneuver using the Pelvic
Organ Prolapse Quantification system (POP-Q, International
Continence Society) [13]. Points C and D were defined as the
leading edge of the vaginal cuff after hysterectomy in patients
who had received hysterectomy. Staging of the vaginal vault
prolapse was based on the position of the vaginal vault apex.
We performed the surgery mostly under general anesthesia
(94.11%) or some with spinal anesthesia depending on the
surgeon’s preference. Premedication included 1 g cefazolin
(Gentle Pharmaceutical Corporation Kashin Medicines, Yun-
lin, Taiwan) given intravenously around 30 minutes prior to
surgery.
The Prolift procedure was performed as previously
described [2]. Briefly, the Prolift, a nonabsorbable, macro-
porous, monofilament soft synthetic mesh, had three types of
mesh: the anterior, posterior, and combined anterior and pos-
terior (Total type). The anterior part was implanted between
the bladder and the vagina and secured on both sides by the
arcus tendineus fascia pelvis. The posterior part was implanted
between the rectum and the vagina and fixed bilaterally at the
sacrospinous ligaments. The intermediated segment of the
mesh corresponded to the vaginal apex, which demarcated
both the anterior and the posterior components. The Total
implant was cut at the midpoint of the middle segment prior to
the anterior and posterior implantation.
To confirm no bladder injury after insertion of the anterior
Prolift, intraoperative cystoscopy was routinely performed.
Absorbable coated 1-0 Vicryl Plus suture (Ethicon) was used
to close the colpotomy. Concomitant surgical procedures such
as vaginal hysterectomy, tension-free vaginal tape-obturator
(Ethicon), and pelvic floor repair were performed as necessary.
Two pieces of 4 cm  4 cm gauze tied in a strip were
packed in the vagina for 24 hours. For infection prophylaxis
and better wound healing, Metronidazole Vaginal Gel (0.75%)
25 g/tube (Sutrol; Panion & BF Biotech Inc, Taipei, Taiwan)
and Premarin Vaginal Cream (0.625 mg/g) 42.5 g/tube (Ayerst
Laboratries, New York, NY, USA) were used 24 hours after
surgery and continued for 2 weeks. The POP-Q stage was
measured by the same surgeon on the follow-up visit at the
outpatient department.
Anatomical failure was defined as at least one compartment
was classified as POP stage  II at 6 months follow-up.
Anatomical success was defined as overall POP stage 0 or I.
The short form of the Urogenital Distress Inventory (UDI)-6
and the Incontinence Impact Questionnaire (IIQ)-7 were used
pre- and postoperatively to evaluate the functional outcome
and quality of life changes. The length of follow-up was
defined as the period from the prolapse surgery to the time that
the patient returned for evaluation for this study (Januarye
February 2011). The patients were divided into two groups:
women followed up for <12 months (Group A) and those
followed up for 12e26 months (Group B) after surgery. The
characteristics of the two groups were compared using an
unpaired t test. The Wilcoxon signed rank test was used for
within-group comparison of variables, whereas the Manne
Whitney U test was used for between-groups comparison of
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expressed as mean  standard deviation. All data analyses
were performed by using SPSS version 17.0 for Windows
(SPSS Inc., Chicago, IL, USA). A p value < 0.05 was
considered statistically significant.
ResultsCharacteristics of the study patientsOf the 34 cases initially included, only 29 completed the
evaluation of the postoperative pelvic floor condition and
questionnaires on functional outcome (mean age, 63.0  9.8
years; range, 38e80 years; Table 1). About 89.7 % (26/29) had
postmenopausal status. Mean parity was 4  1.1 (range,
1e10) and mean body mass index was 23.9  2.7 kg/m2
(range, 16.4e34.0 kg/m2). The mean operation duration was
65.6  30.9 minutes (range, 18e145 minutes), and the mean
blood loss was 89.7  75.2 mL (range, 5e150 mL). The mean
length of hospitalization was 4.0  1.1 days (range, 2e7
days), and the mean length of follow-up was 18  6.3 months
(range, 7e26 months; Table 1). There was no significant dif-
ference in demographic data between the two groups (Group
A: follow-up time <12 months and Group B: >12 months).Table 1
Characteristics of the study population.
Baseline characteristics Group A
(n ¼ 12)a
Group B
(n ¼ 17)b
p Overall
(n ¼ 29)*
Age (y) 62.5  9.26 61.0  11.39 0.689 63.0  9.8
Parity 3.8  1.3 3.7  1.6 0.352 4.0  1.1
Body mass index
(kg/m2)
23.7  2.7 23.4  2.8 0.682 23.9  2.7
Postmenopausal 10 (83.3) 16 (94.1) 0.355 26 (89.7)
Surgical characters
Duration of surgery
(min)
78.7  37.6 64.6  43.7 0.621 65.6  30.9
Blood loss (mL) 119.2  79.6 115.7  109.1 0.602 89.7  75.2
Hospital stay (d) 4  1.2 3.9  1.6 0.687 4.0  1.1
Voiding difficulty 1 (8.3) 1 (5.9) 2 (6.9)
Previous hysterectomy 2 (16.7) 2 (11.8) 4 (13.8)
SUI prior to the
operation
0 2 (11.8) 2 (11.8)
Pelvic organ prolapse
Uterine prolapse 8 (66.7) 10 (58.8) 18 (62.1)
Cystocele 8 (66.7) 11 (64.7) 19 (65.5)
Rectocele 8 (66.7) 7 (41.2) 15 (51.7)
Vaginal vault prolapse 1 (8.3) 3 (17.6) 4 (13.8)
Operations
Total Prolift 6 (50) 11 (64.7) 17 (58.6)
Anterior Prolift 6 (50) 6 (35.3) 12 (41.4)
Transvaginal
hysterectomy
1 (14.3) 2 (11.8) 3 (10.3)
Anterior colporrhaphy 0 1 (5.9) 1 (5.9)
Posterior colporrhaphy 5 (41.7) 1 (5.9) 6 (20.7)
Tension-free vaginal
tape-obturator
1 (14.3) 2 (11.8) 3 (10.3)
Data are presented as mean  standard deviation or n (%).
* Within group comparison with unpaired t test.
a Patients with postoperative follow-up <12 months; b Patients with post-
operative follow-up >12 months.The most common pelvic floor disorders were uterine
prolapse and cystocele (n ¼ 19, 65.5%), followed by uterine
prolapse (n ¼ 18, 62.1%; Table 1). Most patients had more
than one pelvic floor disorder (74%), including 17 who had
uterine prolapse combined with cystocele (45.9%) and 13 who
had uterine prolapse, cystocele, and rectocele (35.13%). Most
of the severity in uterine prolapse, cystocele, and rectocele was
stage 2 or stage 3. Five patients had total uterine prolapse
(14%), four had vaginal vault prolapse (12%), and all of them
had a history of hysterectomy and anterior and posterior col-
porrhaphy, mostly in the late stage (stage 3 or stage 4). Four
women had concomitant stress urinary incontinence (12%)
and two had voiding difficulty prior to surgery.
Major surgeries concomitant with the Prolift repair
included transvaginal hysterectomy in four patients (2 for total
prolapse and 2 who did not want to preserve their uterus),
anterior colporrhaphy in three, and posterior colporrhaphy in
seven. Three out of the four patients who had stress urinary
incontinence received concurrent transvaginal tension-free
vaginal tape-obturator surgery during the prolapse surgery.
There was a difficult case of vaginal vault prolapse recurrence
after two previous prolapsed surgeries.
The mean postoperative POP-Q measurements significantly
improved compared to preoperative values. The improvement
in the 17 patients who were followed-up for >12 months was
even better than that in the 12 patients followed-up for <12
months (Table 2). Postsurgical total vaginal length was not
significantly longer in all 29 patients regardless of the follow-
up time (Table 2).
The success rate of prolapse surgery with Prolift was
100% for uterine prolapse, cystocele, and rectocele. However,
success rate of vaginal vault prolapse was only 75% (Table
3). Pre- and postoperative POP stages of the 29 cases were
noted to establish clear changes in POP stage (Table 3). The
quality of life was significantly improved postoperatively as
shown by better UDI-6 and IIQ-7 scores. The improvement
was statistically significant regardless of the length of follow-
up (Table 4).
There were five cases (5/34, 14.7%) of vault prolapse after
conventional pelvic prolapse surgery with hysterectomy, who
either underwent surgery in our hospital or were referred from
another hospital. All of them received prolapse surgery with
Prolift, and three had anatomically normal vaginal status; one
was eventually lost to follow-up (excluded). There was one
difficult case that had vagina vault prolapse again afterwards.
This case had recurrence of vagina vault prolapse even after
sacrocolpopexy and Halban culdoplasty. We finally did a
colpocleisis by implanting a self-cut polypropylene mesh and
affixing it to the previous anterior and posterior Prolift mesh.Complications and adverse eventsThere were all together 10 adverse events during or after
the prolapse surgery (Table 5). Two cases of bladder injuries
and one case of pararectal fossa and peritoneal injury were
noted during the surgery. Diagnostic laparoscopy was used to
confirm pararectal fossa and peritoneal injury and the injury
Table 2
Anatomical data POP quantification variables.
Group A (n ¼ 12)a Group B (n ¼ 17)b Between groups
comparison, pd
Overall (n ¼ 29)
Pre-op Post-op pc Pre-op Post-op pc Pre-op Post-op
Aa 1.1  1.5 2.9  0.3 0.004 0.4  1.6 2.8  1.0 0.001 0.043 0.7  1.6 2.8  0.7
Ba 2.2  1.6 3.1  0.8 0.002 0.5  2.5 2.9  1.4 0.001 0.351 2.2  1.5 3.1  0.8
C 0.4  3.3 4.8  1.9 0.004 0.6  3.2 5.3  2.3 0.001 0.526 0.4  3.1 4.8  1.8
Ap 0.8  1.7 2.9  0.3 0.002 0.5  1.8 3.0  0 0.001 0.023 0.0  1.7 2.9  0.3
Bp 0.8  2.3 2.9  0.3 0.004 0.4  2.3 2.7  1.2 0.003 0.223 0.8  2.2 2.9  0.3
D 1.1  3.2 5.2  1.0 0.003 1.4  3.3 5.6  2.1 0.001 0.521 1.1  3.0 5.2  1.0
Gh 4.3  1.4 3.5  0.9 0.188 4.4  0.7 3.9  0.8 0.014 0.368 4.3  1.4 3.5  0.9
Pb 2.5  0.5 2.3  0.5 0.437 2.5  0.8 2.2  0.6 0.176 0.419 2.5  0.5 2.3  0.5
TVL 5.6  1.0 5.8  0.8 0.892 6.8  1.3 6.7  1.0 0.748 0.537 5.6  0.9 5.8  0.7
Data are presented as mean  standard deviation.
Aa: anterior vaginal wall 3 cm proximal to the hymen, Ap: posterior vaginal wall 3 cm proximal to the hymen, Ba: most distal portion of the remaining upper
anterior vaginal wall, Bp: most distal portion of the remaining upper posterior vaginal wall, C: most distal edge of cervix or vaginal cuff scar, D: posterior fornix,
Gh: genital hiatus, Pb: perinal body, POP: Pelvic Organ Prolapse, Post-op: postoperative, Pre-op: preoperative; TVL: total vaginal length.
a Patients with postoperative follow-up <12 months; b Patients with postoperative follow-up >12 months; c Within group comparison with Wilcoxon
singed rank test; d Between groups comparison of differences of pre and postoperative values with ManneWhitney U test.
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after prolapse surgery was dyspareunia (3/34, 8.8%), and
others included fixation stiches exposure, difficulty of defe-
cation, severe lower extremity neuralgia/numbness, and mesh
exposure. The adverse symptoms were relieved after removal
of the mesh or stiches. In one patient, severe lower extremity
neuralgia and numbness happened immediately after the
surgery and continued during two follow-up visits at the
outpatient department. Medication gave her only tentative
relief and she was eventually lost to follow-up.
Discussion
The overall anatomical success rate was 96.5% after a mean
follow-up period of 18 months. The anatomical results in the
present study are consistent with those reported by Huang et al
[14], who reported overall anatomical success rate of 97%. In
the present study, 10 cases with uterine prolapse received
uterus-sparing prolapse surgery. Two of these were Stage 4,
three were Stage 3, and five were Stage 2 prolapse prior to
surgery. Both cases of total uterine prolapse had excellent
postoperative anatomical correction, with one as Stage 1 and
the other as Stage 0 at follow-up at 12.5 months and 19.5
months, respectively. Both patients were already menopausal.
In terms of uterine status after prolapse surgery, eight patients
were Stage 0 and the other two patients were Stage 1. In the
past, hysterectomy was considered necessary for POP patientsTable 3
Pre- and postoperative POP-Q stage changes and success rate.
POP No. of
patients
Group A (n ¼ 12)a p No. of patie
Pre-op Post-op
Uterine prolapse 8 3.0  0.7 0.3  0.6 0.012 10
Cystocele 8 2.6  0.5 0.2  0.4 0.038 10
Rectocele 8 1.8  1.0 0.0  0.0 0.050 10
Vault prolapse 1 4.0  0.0 0.0  0.0 <0.001 3
Data are presented as mean  standard deviation.
POP-Q ¼ Pelvic Organ Prolapse Quantification; Post-op ¼ postoperative; Pre-op
a Patients with postoperative follow-up <12 months; b Patients with postoperatwith uterine prolapse, in order to prevent recurrence, espe-
cially for those with concomitant advanced stage uterine
prolapse or obesity. However, there are no conclusive data to
support this concept. By contrast, some studies have revealed
that uterine conservation does not affect POP recurrence [15].
A recent study of prolapse surgery with Prolift in advanced
stage uterine prolapse also demonstrated that uterine preser-
vation is an alternative option with a cure rate of 89.5% [11].
The advantages of uterine preservation include: less inva-
siveness, lower morbidity of visceral organ damage, shorter
surgical time, and decreased recovery period and length of
hospitalization [12]. The data of the present study support the
practical suggestion of Huang et al [11]. Thus, in selected
cases, hysterectomy is unnecessary in prolapse surgery per-
formed with Prolift. However, a randomized clinical trial with
a large sample size is needed to validate this. Uterus-sparing
prolapse surgery is contraindicated if there is current cervi-
cal or intrauterine pathology.
The overall POP-Q improvement of patients followed up
for >12 months was even better than that of patients followed
up for <12 months, especially points Aa and Ap. A possible
explanation is that the mesh coverage was easier and
completed at Aa and Ap compared to points Ba and Bp and the
process of fibrosis made the relative points even higher with
longer follow-up time. Patient selection bias may also have
accounted for this phenomenon because one-third of patients
in Group B received anterior Prolfit only. The subjectivent Group B (n ¼ 17)b p Success
rate
Overall (n ¼ 29)
Pre-op Post-op Pre-op Post-op
2.8  0.9 0.2  0.4 0.004 100% 2.9  0.8 0.2  0.4
2.9  0.7 0.2  0.4 0.020 100% 2.7  0.6 1.2  0.4
2.7  1.1 0.0  0.0 0.017 100% 2.3  1.1 0.0  0.0
3.0  1.0 1.0  1.1 0.019 75% 3.2  0.7 0.8  1.2
¼ preoperative.
ive follow-up >12 months.
Table 4
Symptoms and quality of life scores after prolapsed surgery with Prolift.
Group A (n ¼ 12)a Group B (n ¼ 17)b Between groups
comparison, pd
Overall (n ¼ 29)
Pre-op Post-op pc Pre-op Post-op pc Pre-op Post-op
UDI-6 6.7  3.4 3.1  2.2 0.004 8.2  3.8 3.2  2.5 0.002 0.290 7.7  3.7 3.1  2.3
IIQ-7 7.0  4.9 1.9  2.2 0.002 7.6  5.1 2.5  2.2 0.001 0.873 7.1  4.8 2.2  2.0
Data are presented as mean  standard deviation.
IIQ-7 ¼ short form of the Incontinence Impact Questionnaire; Post-op ¼ postoperative; Pre-op ¼ preoperative; UDI-6 ¼ short form of the Urogenital Distress
Inventory.
a Patients with postoperative follow-up <12 months; b Patients with postoperative follow-up >12 months; c Within group comparison with Wilcoxon
singed rank test; d Between groups comparison of differences of pre and postoperative values with ManneWhitney U test.
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the objective anatomical success. Improvements in the various
domains of UDI and IIQ remained stable between 12 months
and 26 months and were more significant compared to those in
the group followed up for <12 months.
The incidence of vault prolapse is high after conventional
prolapse surgery with hysterectomy. Vault prolapse repair via
open abdominal sacral colpopexy is more effective than tradi-
tional vaginal repairs. However, 75% of the patients with vault
prolapse in the present study had an excellent outcome after
repair with Prolift. Therefore, prolapse surgery with Prolift
seemed to be a rescue for thesewomen. Avaginal approach with
Prolift is a reasonable alternative, especially for those who
cannot tolerate abdominal surgery, have no risk factors for
prolapse recurrence (e.g., obesity or young age), are having
concomitant vaginal surgery, have risk factors for mesh-related
complications (e.g., concomitant hysterectomy, smoking,
immunosuppression, and obesity), or who place a high priority
on a short recovery period or avoiding an abdominal incision.
A randomized trial comparing anterior colporrhaphy and
Prolift for cystocele repair revealed a significant increase in
short-term rates of successful treatment but also higher rates of
surgical complications and postoperative adverse events in the
Prolift group [12]. The total intra- and postoperative adverse
event in this study was 29.41% (Table 5). Bladder injury was
not uncommon because the anchoring route of anterior Prolift
was near to the bladder. Therefore, routine cystoscopic ex-
amination was recommended after surgery. Dyspareunia was
the most common postoperative adverse event in our study
(8.8%). The incidence of dyspareunia was less than that re-
ported in the literature review (17% de novo mild to moderateTable 5
Intra- and postoperative adverse events.
n (%)
Intraoperative
Bladder injury 2 (5.9)
Pararectal fossa and peritoneal injury 1 (2.9)
Postoperative
Dyspareunia 3 (8.8)
Accumulated mesh exposure (12 mo) 1 (2.9)
Fixation stiches exposure 1 (2.9)
Difficulty of defecation 1 (2.9)
Severe lower extremity neuralgia and numbness 1 (2.9)
Total 10 (29.41)dyspareunia) [16]. This may have been due to underestima-
tion, because the condition of sexual activities or satisfaction
was not routinely asked during the interview. The present
study abandoned the use of nonabsorbable fixation sutures for
mesh after two cases, because it is not necessary and may be
exposed if not well covered, especially when the vaginal
mucosa of the patient is atrophied or thin. A complicated case
complained of sciatica immediately after the operation and
subsequently; analgesia only gave her slight relief. She was
eventually lost to follow-up after two visits to the outpatient
department. Although there is great potential for pudendal
nerve injury during surgery because it is close to the sacro-
spinous ligament, injury to the branch of the sciatic nerve or
irritation of the spinal nerves near the lumbar area may occur.
Sciatica is seldom dangerous and rarely leads to surgical
intervention. Most patients with this condition can manage the
pain with medication and physical therapy. Although serious
complications were uncommon in Prolift surgery, patients
should be informed of all potential complications, as well as
alternative choices of treatment.
There were some limitations to our study. Measurement bias
may have been present because not all the POP-Q measure-
ments were performed by an independent examiner. There was
no control group for comparison. Moreover, the case number
was not large enough to produce convincing conclusions.
Indeed, asking patients to join the study and return to the
outpatient department was difficult, especially in eastern
Taiwan because of the longitudinal topography and many pa-
tients lived far from the hospital. Although the numbers of
patients in the two groups were uneven, their baseline or sur-
gical characteristics did not differ significantly. As mentioned
above, only 58.6% of the patients were followed up for >12
months, and this period was not long enough to establish the
long-term outcome of the device in pelvic prolapse surgery.
In conclusion, Prolift surgery provides good anatomical
outcome and satisfactory symptom improvement at different
periods of follow-up. Uterus-sparing prolapse surgery with
Prolift also has good results. Patients should be fully informed
of possible adverse events of the device before it is used.References
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